Speaker illustration

Professor Salvatore Di Somma

Sapienza University of Rome, Rome (Italy)

Member of:

Graduate in Medicine “cum laude”, 1978. Post Graduate “cum Laude” in Internal Medicine ), 1983. Post Graduate “cum Laude” in Cardiology , 1987. Professor of Internal Medicine, Cardiologist and Internist at Faculty of Medicine and Psicology, Department of Medical and Surgery Sciences and Translational Medicine ,at University “La Sapienza” Rome ,Italy and Director Emergency Medicine and postgraduate School of Emergency Medicine ,Faculty of Medicine and Psicology, University “La Sapienza” Rome since 2001;where he worked as Director of ED at Sant’Andrea Hospital from 2001 at 2016. Previously he had University formation and positions at Clinical and Experimental Medicine Department at Medical School of ’University “Federico II” in Naples and Professor Assistant at the Cardiovascular Research Institute at New York Medical College from 1994 to 1996. From 2017 Visiting Professor UCSD Health Center UCSD USA and Expert Professor Department of Medicine Lund University Sweden.

Moderated Poster Session: Everlasting questions, new answers

Event: Heart Failure 2019

Topic: Other

Session type: Moderated Posters

Thumbnail

Emerging concepts in acute heart failure

Event: Acute Cardiovascular Care 2019

Topic: Acute Heart Failure

Session type: Symposium

Thumbnail

Moderated Poster session 1 - Prognosis

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Miscellaneous

Session type: Moderated Posters

Thumbnail

The patient with dyspnea in the emergency department

Event: Acute Cardiovascular Care 2016

Topic: Acute Heart Failure

Session type: Symposium

Thumbnail

The use of biomarkers in ACS and heart failure

Event: Acute Cardiovascular Care 2016

Topic: Biomarkers

Session type: Symposium

Thumbnail

Implementation of heart failure guidelines in clinical practice

Event: HEART FAILURE 2016

Topic: Disease management programmes

Session type: Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb